RIZATRIPTAN Mepha oro cpr orodisp 5 mg 6 pce

7680657990010 CH-65799 N02CC04 02.05.1.
RIZATRIPTAN Mepha oro cpr orodisp 5 mg 6 pce
RIZATRIPTAN Mepha oro cpr orodisp 5 mg 6 pce
RIZATRIPTAN Mepha oro cpr orodisp 5 mg 6 pce
1 / 3
google

Details

Product number
6579901
CPT
-
Packaging group
6
Unit
Tablette(n)
Composition
rizatriptanum 5 mg ut rizatriptani benzoas, mannitolum, cellulosum microcristallinum, maltodextrinum, silica colloidalis anhydrica, crospovidonum, saccharinum natricum corresp. natrium 0.03 mg, aromatica (Menthol), amylum modificatum, magnesii stearas, pro compresso.

Articles (1)

Rizatriptan-Mepha oro 5 mg, Schmelztabletten
Schmelztabletten
6
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
02/06/2023
Patient information leaflet
Français
02/06/2023
Patient information leaflet
Italien
02/06/2023
Professional SmPC
Allemand
02/06/2023
Professional SmPC
Français
02/06/2023
Professional SmPC
Italien
02/06/2023

Detailed composition

Substance Quantity Type Category
(N/A)
5.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance AIMDK
(N/A)
0.03 MG Substance HBESI
(N/A)
- Substance AROMA
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 39.10
Specialties list
Yes
Generic
Yes
SL addition date: 01/08/2015

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
65799
Drug name
Rizatriptan-Mepha oro, Schmelztabletten
Galenic form
SCHM
ATC Code
N02CC04
Authorization status
Z
Authorization category
Category C
Dispensation category
B
First authorization
22/05/2015
Authorization expiration date
31/12/9999
IT number
02.05.1.
Domain
Human medicine
Field of application
Akutbehandlung von Migräneanfällen mit oder ohne Aura

Packaging details

Description (FR)
RIZATRIPTAN Mepha oro cpr orodisp 5 mg 6 pce
Description (DE)
RIZATRIPTAN Mepha oro Schmelztabl 5 mg 6 Stk
Market launch
22/05/2015
Narcotic (BTM)
No

Original drug

Maxalt lingual, Schmelztabletten
CHF 41.20
View original

Other packaging sizes

RIZATRIPTAN Mepha oro cpr orodisp 10 mg 3 pce
3 TABL
View
RIZATRIPTAN Mepha oro cpr orodisp 10 mg 6 pce
6 TABL
View
RIZATRIPTAN Mepha oro cpr orodisp 10 mg 12 pce
12 TABL
View